Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile
Sara G. Gil-Perotin

@gilperotin

Neuroimmunologist, ICU, person-centered, avid book reader, women’s rights defender, mother. This is my opinion.

ID: 1490739116635561987

calendar_today07-02-2022 17:28:23

657 Tweet

324 Followers

555 Following

Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile Photo

Proud to contribute to this EBMT Autoimmune Diseases Working Party study showing no efficacy or safety differences among the main conditioning regimens used in autologous HSCT for Multiple Sclerosis. nature.com/articles/s4140…

Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile Photo

Creo que la gerencia del hospital de esta doctora no actuó por razones científicas. Espero que se haga justicia #metoo hospitales . Tu justicia será la de muchas otras mujeres que sufren situaciones similares en el ámbito científico y hospitalario.

Elia Sechi (@eliasechi) 's Twitter Profile Photo

Applying the Supporting Features for MOGAD Diagnosis to Patients With Multiple Sclerosis | Neurology Neuroimmunology & Neuroinflammation neurology.org/doi/10.1212/NX… Pietro Zara Matteo Gastaldi Sara Mariotto Rosa Cortese Sara Carta and Giacomo Greco 🇮🇹💣

Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile Photo

In Vivo CD19 CAR T-Cell Therapy for Refractory Systemic Lupus Erythematosus | New England Journal of Medicine nejm.org/doi/full/10.10…

Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile Photo

¿En qué momento la ciencia y el buen hacer científico comenzaron a medirse por índices de impacto y no por repercusión real?

Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile Photo

Anti-BCMA CAR-T therapy in patients with progressive multiple sclerosis: Cell- after a quick read. Very impressive 😮. #multiplesclerosis #progressive #PMS cell.com/cell/fulltext/…

Joe Sabatino (@jsabatino37) 's Twitter Profile Photo

Really exciting new work on presymptomatic biomarkers in #multiplesclerosis from Ahmed Abdelhak, Ari Green, and colleagues at UCSF nature.com/articles/s4159…

Morin Beyeler, MD (@morin_beyeler) 's Twitter Profile Photo

Cancer-related strokes are difficult to manage, synonym of bad prognosis and still poorly understood, which is why I did my clinical PhD on this exciting topic. It is now published online, check it out!😉: boristheses.unibe.ch/6822 Stroke Research Center Bern Faculty of Medicine, University of Bern

Cancer-related strokes are difficult to manage, synonym of bad prognosis and still poorly understood, which is why I did my clinical PhD on this exciting topic. 
It is now published online, check it out!😉: boristheses.unibe.ch/6822
<a href="/StrokeBern/">Stroke Research Center Bern</a> <a href="/MedFacultyUniBE/">Faculty of Medicine, University of Bern</a>
Pluchino lab - Regenerative Neuroimmunology (@pluchinolab) 's Twitter Profile Photo

The gain-of-function TREM2-T96K mutation increases risk for Alzheimer’s disease by impairing microglial function sciencedirect.com/science/articl…

MSJ (@msj_research) 's Twitter Profile Photo

Among >300 proteins investigated by NUcleic Acid-Linked Immuno-Sandwich Assay in #MultipleSclerosis, GFAP was the main correlate of progression independent of relapse activity. Study from Sofia Sandgren Sahlgrenska Academy Jens Kuhle RC2NB Universität Basel ▶️ journals.sagepub.com/doi/full/10.11…

Among &gt;300 proteins investigated by NUcleic Acid-Linked Immuno-Sandwich Assay in #MultipleSclerosis, GFAP was the main correlate of progression independent of relapse activity.

Study from <a href="/SofiaSandgren1/">Sofia Sandgren</a> <a href="/SahlgrenskaAcad/">Sahlgrenska Academy</a> <a href="/JensKuhle/">Jens Kuhle</a> <a href="/RC2NB/">RC2NB</a> <a href="/UniBasel/">Universität Basel</a>  ▶️ journals.sagepub.com/doi/full/10.11…
Esclerosis Múltiple (@esclerosiseme) 's Twitter Profile Photo

💥 ¡Un avance esperanzador en la lucha contra la Esclerosis Múltiple! Emily, madre y profesora británica, ha sido la primera persona en recibir una terapia celular experimental con células CAR-T que podría detener o incluso revertir la progresión de la enfermedad. Su

💥 ¡Un avance esperanzador en la lucha contra la Esclerosis Múltiple!

Emily, madre y profesora británica, ha sido la primera persona en recibir una terapia celular experimental con células CAR-T que podría detener o incluso revertir la progresión de la enfermedad.

Su
Sara G. Gil-Perotin (@gilperotin) 's Twitter Profile Photo

De la librería que mi madre atesoraba y que heredé prematuramente, hace unos años desempolvé y leí #EsperandoaGodot. La veré finalmente en su formato original (teatro) interpretada por uno de los actores fetiche de mi adolescencia.

De la librería que mi madre atesoraba y que heredé prematuramente, hace unos años desempolvé y leí  #EsperandoaGodot. La veré finalmente en su formato original (teatro) interpretada por uno de los actores fetiche de mi adolescencia.
Joe Sabatino (@jsabatino37) 's Twitter Profile Photo

Dynamic relationship between cerebrospinal fluid immune cells and tissue damage markers in multiple sclerosis academic.oup.com/braincomms/art…